Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
This brief overview contrasts index and target date retirement funds, outlining core differences and practical tips to help you choose the right option.
25,442 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
As both ServiceNow and UiPath trade at appealing valuations, investors face a key question: should servicenow stock i...
A market thinker known as the prophet ‘wired belt’ warns that AI-driven shifts are hollowing out knowledge-economy jo...
When rates rise, bank stocks can outperform. This guide reveals why the Invesco KBW Bank ETF (KBWB) may be the smarte...
A celebrity moment about mom-shaming becomes a real-world lesson in personal finance. Learn practical steps to safegu...
Resolute Holdings stock soars can signal a potent momentum move. This guide breaks down the drivers, evaluates sustai...
A niche nuclear tech stock reported solid revenue gains, but a large fund reduced its holdings. Learn how to read the...
After a slow stretch for home sales, many buyers and investors wonder if 2026 will flip the script. This guide breaks...
Investors are weighing Alibaba's prospects after a tough stretch. This guide examines whether alibaba stock rebound c...
Nvidia has cooled off after a blistering run, but a dip doesn’t automatically mean a deal. This guide walks you throu...
A $10,000 investment in Asia’s biggest stocks grew to $15,267 by June 3, 2026, outpacing most U.S. large caps and hig...
Virtus InfraCap’s new VPFF ETF started trading in July 2026, offering 0.80% expenses and an actively managed approach...